$400M Pfizer Class Action Deal Gets OK From Judge
A New York federal judge on Thursday granted final approval of a $400 million settlement that ends a class action accusing Pfizer Inc. of misleading investors about illegal off-label drug marketing,...To view the full article, register now.
Already a subscriber? Click here to view full article